MyoKardia is dedicated to revolutionizing the treatment of cardiovascular disease. The company's first programs include hypertrophic and dilated cardiomyopathy (HCM and DCM), which together afflict approximately 1 million people in the United States, and for which no novel therapeutics have been brought to market in over a decade.


There are no scholarships at this time


There are no events at this time

Company Data on MyoKardia
provided by Owler


MyoKardia is hiring for these positions

Show me: All available jobs